{
  "id": "7c9b4279af0e3a44",
  "title": "Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4 - Related Disease ( IgG4 - RD ) ",
  "description": "20260105T210000Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2026/01/05/1428782/zenas-biopharma-announces-positive-results-from-phase-3-indigo-registrational-trial-of-obexelimab-in-immunoglobulin-g4-related-disease-igg4-rd/",
  "published_at": "20260105T210000Z",
  "fetched_at": "2026-01-06T00:23:36.488656+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2026/01/05/1428782/zenas-biopharma-announces-positive-results-from-phase-3-indigo-registrational-trial-of-obexelimab-in-immunoglobulin-g4-related-disease-igg4-rd/",
    "url_mobile": "",
    "title": "Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4 - Related Disease ( IgG4 - RD ) ",
    "seendate": "20260105T210000Z",
    "socialimage": "https://ml.globenewswire.com/media/MjYyZTEwMmUtNzJmYy00NzBhLTgzNmEtZDkxNmM0ZmY0NjNiLTEyMTkzNDgtMjAyNi0wMS0wNS1lbg==/tiny/Zenas-BioPharma-USA-LLC.png",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}